150 related articles for article (PubMed ID: 24413475)
1. The fentanyl 'lozenge' story: from books to battlefield.
Aldington D; Jagdish S
J R Army Med Corps; 2014 Jun; 160(2):102-4. PubMed ID: 24413475
[TBL] [Abstract][Full Text] [Related]
2. Fentanyl lozenge story part 2: from military procurement to package.
Rogers E; Wright C; King P
J R Army Med Corps; 2018 Nov; 164(6):458-462. PubMed ID: 29440467
[TBL] [Abstract][Full Text] [Related]
3. Acute pain on and off the battlefield: what we do, what we know, and future directions.
Kent ML; Upp JJ; Buckenmaier CC
Int Anesthesiol Clin; 2011; 49(3):10-32. PubMed ID: 21697667
[No Abstract] [Full Text] [Related]
4. Battlefield acupuncture: Opening the door for acupuncture in Department of Defense/Veteran's Administration health care.
Walker PH; Pock A; Ling CG; Kwon KN; Vaughan M
Nurs Outlook; 2016; 64(5):491-8. PubMed ID: 27601311
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of oral transmucosal fentanyl citrate for prehospital pain control on the battlefield.
Wedmore IS; Kotwal RS; McManus JG; Pennardt A; Talbot TS; Fowler M; McGhee L
J Trauma Acute Care Surg; 2012 Dec; 73(6 Suppl 5):S490-5. PubMed ID: 23192075
[TBL] [Abstract][Full Text] [Related]
6. Military pain management in 21st century war.
Buckenmaier CC; Griffith S
Mil Med; 2010 Jul; 175(7 Suppl):7-12. PubMed ID: 23634472
[TBL] [Abstract][Full Text] [Related]
7. A patient-activated iontophoretic transdermal system for acute pain management with fentanyl hydrochloride: overview and applications.
Bain KT
J Opioid Manag; 2006; 2(6):314-24. PubMed ID: 17326593
[TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
9. Fentanyl buccal tablet for breakthrough cancer pain: why titrate?
Kleeberg UR; Filbet M; Zeppetella G
Pain Pract; 2011; 11(2):185-90. PubMed ID: 20807349
[TBL] [Abstract][Full Text] [Related]
10. Fast-acting fentanyl preparations and pain management.
McWilliams K; Fallon M
QJM; 2013 Oct; 106(10):887-90. PubMed ID: 23613597
[TBL] [Abstract][Full Text] [Related]
11. The management of wound-related procedural pain (volitional incident pain) in advanced illness.
Gallagher R
Curr Opin Support Palliat Care; 2013 Mar; 7(1):80-5. PubMed ID: 23150425
[TBL] [Abstract][Full Text] [Related]
12. Treatment of breakthrough pain with fentanyl buccal tablet in opioid-tolerant patients with chronic pain: appropriate patient selection and management.
Fine PG; Narayana A; Passik SD
Pain Med; 2010 Jul; 11(7):1024-36. PubMed ID: 20642730
[TBL] [Abstract][Full Text] [Related]
13. Fentanyl buccal tablet (Fentora) for breakthrough pain.
Med Lett Drugs Ther; 2007 Sep; 49(1270):78-9. PubMed ID: 17878889
[No Abstract] [Full Text] [Related]
14. Equivalency of two concentrations of fentanyl administered by the intranasal route for acute analgesia in children in a paediatric emergency department: a randomized controlled trial.
Borland M; Milsom S; Esson A
Emerg Med Australas; 2011 Apr; 23(2):202-8. PubMed ID: 21489168
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines.
Aronoff GM; Brennan MJ; Pritchard DD; Ginsberg B
Pain Med; 2005; 6(4):305-14. PubMed ID: 16083461
[TBL] [Abstract][Full Text] [Related]
16. Safety alert for fentanyl buccal tablets.
U.S. Food and Drug Administration
J Pain Palliat Care Pharmacother; 2008; 22(1):47. PubMed ID: 19062355
[TBL] [Abstract][Full Text] [Related]
17. Shell shock.
Ashton E
J R Army Med Corps; 2014 Jun; 160 Suppl 1():i11-2. PubMed ID: 24845886
[No Abstract] [Full Text] [Related]
18. Intranasal fentanyl for acute pain: techniques to enhance efficacy.
Wolfe T
Ann Emerg Med; 2007 May; 49(5):721-2. PubMed ID: 17452275
[No Abstract] [Full Text] [Related]
19. Fentanyl pectin nasal spray for breakthrough cancer pain.
Taylor DR; Gabrail N
Future Oncol; 2012 Feb; 8(2):121-30. PubMed ID: 22335576
[TBL] [Abstract][Full Text] [Related]
20. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
Webster LR; Slevin KA; Narayana A; Earl CQ; Yang R
Pain Med; 2013 Sep; 14(9):1332-45. PubMed ID: 23855816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
